亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Abstract LB092: Novel tumor gene expression signatures predictive of outcome in large B cell lymphoma treated with CAR T cell therapy (axicabtagene ciloleucel)

医学 淋巴瘤 肿瘤科 癌症研究 内科学
作者
Yuan Tian,Justin A. Budka,Frederick L. Locke,Jason R. Westin,Christina To,Shilpa Shahani,Davide Bedognetti,Rhine R. Shen,Jorge Andrade,Simone Filosto
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (7_Supplement): LB092-LB092
标识
DOI:10.1158/1538-7445.am2024-lb092
摘要

Abstract We leveraged ZUMA-7, the first and largest, phase III randomized CAR-T cell clinical study of relapsed/refractory large B cell lymphoma (LBCL) in the 2nd line setting, to discover tumor gene expression (GE) signatures associated with outcome to anti-CD19 CAR-T cell therapy, Axicabtagene Ciloleucel (axi-cel). We performed GE profiling on pre-treatment LBCL tumor samples from 134 axi-cel-treated (safety dataset) patients using IO-360 Nanostring panel (769 genes). Multivariate analysis with penalized Cox models was conducted to identify genes whose expression (transcripts) associated with event-free survival (EFS), progression-free survival (PFS), and duration of response (DOR), leading to identification of two predictive GE signatures. For technical validation, the predictive value of these signatures was reproduced in a subset of ZUMA-7 samples profiled by RNA-seq (n=124). High levels (> median) of a favorable 6-transcript GE signature (6-GES) composed of CD19, CD45RA, CCL22, KLRK1, SOX11, and SIGLEC5 positively correlated with EFS (HR: 0.27, 95% CI: 0.16–0.44; P=1.82 × 10−8) and PFS (HR: 0.27, 95% CI: 0.16–0.46; P=1.35 × 10−7) in patients treated with axi-cel. The 6-GES may capture lymphomas with abundant adhesion molecules, a relatively low inflammation, and abundant expression of the targeted antigen (CD19). Conversely, high levels of an unfavorable 17-transcript GE signature (17-GES; CD45RO, BCL2, IL-18R1, TNFSF4 [OX40L], KLRB1 [CD161], KIR3DL2, ITGB8, DUSP5, GPC4, PSMB5, RPS6KB1, SERPINA9, NBN, GLUD1, ESR1, ARID1A, and SLC16A1) negatively correlated with Axi-cel EFS (HR: 6.19, 95% CI: 3.60–10.65; P=1.51 × 10−13) and PFS (HR: 7.58, 95% CI: 4.16–13.81; P=2.70 × 10−14). The 17-GES signature is consistent with a high level of immune infiltration and inflammation paralleled by the activation of immune-escape mechanisms, such as the upregulation of anti-apoptotic genes. Notably, the 17-GES was elevated at progression after axi-cel treatment (n=18). These signatures did not associate with outcome to 2nd-line SOC from ZUMA-7 (n = 122 for nanostring and n = 125 for ZUMA-7 RNAseq datasets, respectively), nor with outcome to 1st -line R-CHOP from two online datasets, indicating their predictive rather than prognostic value. In conclusion, our transcriptomic analysis of ZUMA-7 dataset identified novel GE signatures predictive of outcome with axi-cel. These GE signatures could support risk-stratification of LBCL patients. Citation Format: Yuan Tian, Justin Budka, Frederick L. Locke, Jason R. Westin, Christina To, Shilpa Shahani, Davide Bedognetti, Rhine R. Shen, Jorge Andrade, Simone Filosto. Novel tumor gene expression signatures predictive of outcome in large B cell lymphoma treated with CAR T cell therapy (axicabtagene ciloleucel) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl):Abstract nr LB092.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
12秒前
机智迎天完成签到 ,获得积分10
19秒前
HS完成签到,获得积分10
25秒前
41秒前
Mong那粒沙完成签到,获得积分10
49秒前
zhang_23完成签到,获得积分10
52秒前
luna完成签到 ,获得积分10
53秒前
55秒前
1分钟前
haha发布了新的文献求助30
1分钟前
搜集达人应助ceeray23采纳,获得111
1分钟前
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
1分钟前
2分钟前
haha完成签到,获得积分10
2分钟前
wefor完成签到 ,获得积分10
2分钟前
yht完成签到,获得积分10
2分钟前
Perion完成签到 ,获得积分10
2分钟前
ZengLY完成签到 ,获得积分10
2分钟前
啊啊啊啊啊啊啊啊啊啊完成签到 ,获得积分10
3分钟前
3分钟前
小蘑菇应助科研通管家采纳,获得10
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
3分钟前
科研通AI2S应助觅越采纳,获得10
3分钟前
yht发布了新的文献求助10
4分钟前
爆米花应助kingJames采纳,获得10
4分钟前
charih完成签到 ,获得积分10
4分钟前
剑指东方是为谁完成签到,获得积分10
4分钟前
zenabia完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
ceeray23发布了新的文献求助111
4分钟前
lezbj99完成签到,获得积分10
4分钟前
俏皮火完成签到 ,获得积分10
5分钟前
5分钟前
wpj发布了新的文献求助10
5分钟前
5分钟前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 2000
Applications of Emerging Nanomaterials and Nanotechnology 1111
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Neuromuscular and Electrodiagnostic Medicine Board Review 700
지식생태학: 생태학, 죽은 지식을 깨우다 600
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3466817
求助须知:如何正确求助?哪些是违规求助? 3059596
关于积分的说明 9067206
捐赠科研通 2750080
什么是DOI,文献DOI怎么找? 1508953
科研通“疑难数据库(出版商)”最低求助积分说明 697124
邀请新用户注册赠送积分活动 696896